1. Analysis of a Phase 2b Study of GEN-003, a Genital Herpes Immunotherapy, Showed Significant Reductions in Viral Shedding and Lesion Rate Vs Placebo. (4th October 2017) Authors: Heineman, Thomas C; Bernstein, David; Wald, Anna; Van Wagoner, Nicholas; Leone, Peter; Mayer, Kenneth; Lucksinger, Gregg; Win, Sandra; Koltun, William; Desai, Nisha; Oliphant, Thomas; Natenshon, Andrew; McNeil, Lisa K; Flechtner, Jessica B; Hetherington, Seth Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Forty-eight-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1. (4th October 2017) Authors: Emu, Brinda; Fessel, W Jeffery; Schrader, Shannon; Kumar, Princy N; Richmond, Gary; Win, Sandra; Weinheimer, Steven; Marsolais, Christian; Lewis, Stanley Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗